Table 3 |
|||
|
Pilot Study - Checklist: Items to include when reporting a pilot study |
|||
|
PAPER SECTION |
Item |
Descriptor |
Reported on Page # |
|
|
|||
|
TITLE and ABSTRACT |
1 |
Does the title or abstract indicate that the study is a "pilot"? |
|
|
|
|||
|
INTRODUCTION |
|||
|
Background |
2 |
Scientific background for the main study and explanation of rationale for assessing feasibility through piloting |
|
|
|
|||
|
METHODS |
|||
|
Participants and setting |
3 |
• Eligibility criteria for participants in the pilot study (these should be the same as in the main study -- if different, state the differences) |
|
|
• The settings and locations where the data were collected |
|||
|
|
|||
|
Interventions |
4 |
Provide precise details of the interventions intended for each group and how and when they were actually administered (if applicable) -- state clearly if any aspects of the intervention are assessed for feasibility |
|
|
|
|||
|
Objectives |
5 |
• Specific scientific objectives and hypotheses for the main study |
|
|
• Specific feasibility objectives |
|||
|
|
|||
|
Outcomes |
6 |
• Clearly defined primary and secondary outcome measures for the main study |
|
|
• Clearly define the feasibility outcomes and how they were operationalized -- these should include key elements such as recruitment rates, consent rates, completion rates, variance estimates, etc |
|||
|
|
|||
|
Sample size |
7 |
Describe how sample size was determined |
|
|
• In general for a pilot of a phase III trial, there is no need for a formal sample size calculation. However, confidence interval approach may be used to calculate and justify the sample size based on key feasibility objective(s). |
|||
|
|
|||
|
Feasibility Criteria |
8 |
Clearly describe the criteria for assessing success of feasibility -- these should be based on the feasibility objectives |
|
|
|
|||
|
Statistical Methods |
9 |
Describe the statistical methods for the analysis of primary and secondary feasibility outcomes |
|
|
|
|||
|
Ethical Aspects |
10 |
• State whether the study received research ethics approval |
|
|
• State how informed consent was handled -- given the feasibility nature of the study |
|||
|
|
|||
|
RESULTS |
|||
|
Participant flow |
11 |
Flow of participants through each stage (a flow-chart is strongly recommended). |
|
|
• Describe protocol deviations from pilot study as planned, together with reasons |
|||
|
• State the number of exclusions at each stage and reasons for exclusions |
|||
|
|
|||
|
Recruitment |
12 |
Report the dates defining the periods of recruitment and follow-up |
|
|
|
|||
|
Baseline data |
13 |
Report the baseline demographic and clinical characteristics of the participants |
|
|
|
|||
|
Outcomes and estimation |
14 |
For each primary and secondary feasibility outcome, report the point estimate of effect and its precision (e.g., 95% confidence interval [CI]) -- if applicable |
|
|
|
|||
|
DISCUSSION |
|||
|
Interpretation |
15 |
Interpretation of the results should focus on feasibility, taking into account |
|
|
• the stated criteria for success of feasibility; |
|||
|
• study hypotheses, sources of potential bias or imprecision -- given the feasibility nature of the study |
|||
|
• the dangers associated with multiplicity of analyses and outcomes |
|||
|
|
|||
|
Generalizability |
16 |
Generalizability (external validity) of the feasibility. State clearly what modifications in the design of the main study (if any) would be necessary to make it feasible |
|
|
|
|||
|
Overall evidence of feasibility |
17 |
General interpretation of the results in the context of current evidence of feasibility |
|
|
• Focus should be on feasibility |
|||
|
|
|||
|
Thabane et al. BMC Medical Research Methodology 2010 10:1 doi:10.1186/1471-2288-10-1 |
|||